These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

659 related articles for article (PubMed ID: 32213338)

  • 41. Clinical and psychometric validation of the EORTC QLQ-CR29 questionnaire module to assess health-related quality of life in patients with colorectal cancer.
    Whistance RN; Conroy T; Chie W; Costantini A; Sezer O; Koller M; Johnson CD; Pilkington SA; Arraras J; Ben-Josef E; Pullyblank AM; Fayers P; Blazeby JM;
    Eur J Cancer; 2009 Nov; 45(17):3017-26. PubMed ID: 19765978
    [TBL] [Abstract][Full Text] [Related]  

  • 42. An international validation study of the EORTC brain cancer module (EORTC QLQ-BN20) for assessing health-related quality of life and symptoms in brain cancer patients.
    Taphoorn MJ; Claassens L; Aaronson NK; Coens C; Mauer M; Osoba D; Stupp R; Mirimanoff RO; van den Bent MJ; Bottomley A;
    Eur J Cancer; 2010 Apr; 46(6):1033-40. PubMed ID: 20181476
    [TBL] [Abstract][Full Text] [Related]  

  • 43. International validation of the EORTC QLQ-PRT20 module for assessment of quality of life symptoms relating to radiation proctitis: a phase IV study.
    Halkett GKB; Wigley CA; Aoun SM; Portaluri M; Tramacere F; Livi L; Detti B; Arcangeli S; Lund JA; Kristensen A; McFadden N; Grun A; Bydder S; Sackerer I; Greimel E; Spry N;
    Radiat Oncol; 2018 Aug; 13(1):162. PubMed ID: 30157890
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Psychometric analysis of a Persian version of the European Organization for Research and Treatment of Cancer OG25 Quality of Life Questionnaire in oesophagogastric cancer patients.
    Hesari AE; Lari MA; Shandiz FH
    Asian Pac J Cancer Prev; 2014; 15(6):2739-45. PubMed ID: 24761894
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology.
    Aaronson NK; Ahmedzai S; Bergman B; Bullinger M; Cull A; Duez NJ; Filiberti A; Flechtner H; Fleishman SB; de Haes JC
    J Natl Cancer Inst; 1993 Mar; 85(5):365-76. PubMed ID: 8433390
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The construction and testing of the EORTC colorectal cancer-specific quality of life questionnaire module (QLQ-CR38). European Organization for Research and Treatment of Cancer Study Group on Quality of Life.
    Sprangers MA; te Velde A; Aaronson NK
    Eur J Cancer; 1999 Feb; 35(2):238-47. PubMed ID: 10448266
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Reliability, validity and responsiveness of the Mandarin (Simplified) Chinese version of the EORTC QLQ-OH45 among cancer patients.
    Liu J; Gao J; Wu CX; Bai DX; Li X; Guo XX; Yu JY; Xiao QQ; Bao XR; He LC; Zhong YZ; Chen S
    Eur J Cancer Care (Engl); 2019 Mar; 28(2):e12987. PubMed ID: 30614580
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Validation and reliability of the Dutch version of the EORTC QLQ-NMIBC24 Questionnaire Module for patients with non-muscle-invasive bladder cancer.
    Ripping TM; Westhoff E; Aaronson NK; Van Hemelrijck M; Rammant E; Witjes JA; Kiemeney LA; Aben KKH; Vrieling A
    J Patient Rep Outcomes; 2021 Sep; 5(1):96. PubMed ID: 34542736
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The EORTC QLQ-OH17: a supplementary module to the EORTC QLQ-C30 for assessment of oral health and quality of life in cancer patients.
    Hjermstad MJ; Bergenmar M; Fisher SE; Montel S; Nicolatou-Galitis O; Raber-Durlacher J; Singer S; Verdonck-de Leeuw I; Weis J; Yarom N; Herlofson BB
    Eur J Cancer; 2012 Sep; 48(14):2203-11. PubMed ID: 22572480
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Development and Validation of the Korean Version of the European Organization for Research and Treatment of Cancer Quality of Life Questionnaire for Patients with Non-muscle Invasive Bladder Cancer: EORTC QLQ-NMIBC24.
    Park J; Shin DW; Kim TH; Jung SI; Nam JK; Park SC; Hong S; Jung JH; Kim H; Kim WT
    Cancer Res Treat; 2018 Jan; 50(1):40-49. PubMed ID: 28279061
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Psychometric analysis of the Korean version of the high-dose chemotherapy specific quality of life questionnaire module from the European Organization for Research and Treatment of Cancer (EORTC QLQ-HDC29).
    Kim KI; Kim JH; Ji EH; Jang JH; Kim JS; Kwon JH; Kim I; Park S; Velikova G; Yoon SS; Oh JM
    Qual Life Res; 2016 Apr; 25(4):881-90. PubMed ID: 26342931
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The Azeri Version of European Organization for Research and Treatment of Cancer Core Quality of Life Questionnaire (EORTC QLQ-C30): Translation and Validation.
    Davudov MM; Harirchi I; Amiraliyev N; Mehtiyeva E; Mirzajani Z; Amiraliyev K; Rustamli N; Zebardast J; Montazeri A
    Asian Pac J Cancer Prev; 2020 Jan; 21(1):267-271. PubMed ID: 31983195
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Validation and reliability testing of the EORTC QLQ-NMIBC24 questionnaire module to assess patient-reported outcomes in non-muscle-invasive bladder cancer.
    Blazeby JM; Hall E; Aaronson NK; Lloyd L; Waters R; Kelly JD; Fayers P
    Eur Urol; 2014 Dec; 66(6):1148-56. PubMed ID: 24612661
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The development and psychometric validation of a brain cancer quality-of-life questionnaire for use in combination with general cancer-specific questionnaires.
    Osoba D; Aaronson NK; Muller M; Sneeuw K; Hsu MA; Yung WK; Brada M; Newlands E
    Qual Life Res; 1996 Feb; 5(1):139-50. PubMed ID: 8901377
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Quality of life of lung cancer patients: validation of the Taiwan Chinese version of the EORTC QLQ-C30 and QLQ-LC13.
    Chie WC; Yang CH; Hsu C; Yang PC
    Qual Life Res; 2004 Feb; 13(1):257-62. PubMed ID: 15058806
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The EORTC CAT Core-The computer adaptive version of the EORTC QLQ-C30 questionnaire.
    Petersen MA; Aaronson NK; Arraras JI; Chie WC; Conroy T; Costantini A; Dirven L; Fayers P; Gamper EM; Giesinger JM; Habets EJJ; Hammerlid E; Helbostad J; Hjermstad MJ; Holzner B; Johnson C; Kemmler G; King MT; Kaasa S; Loge JH; Reijneveld JC; Singer S; Taphoorn MJB; Thamsborg LH; Tomaszewski KA; Velikova G; Verdonck-de Leeuw IM; Young T; Groenvold M;
    Eur J Cancer; 2018 Sep; 100():8-16. PubMed ID: 29936066
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Psychometric Validation of the Malaysian Chinese Version of the EORTC QLQ-C30 in Colorectal Cancer Patients.
    Magaji BA; Moy FM; Roslani AC; Law CW; Sagap I
    Asian Pac J Cancer Prev; 2015; 16(18):8107-12. PubMed ID: 26745046
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The validation of the standard Chinese version of the European Organization for Research and Treatment of Cancer Quality of Life Core Questionnaire 30 (EORTC QLQ-C30) in pre-operative patients with brain tumor in China.
    Cheng JX; Liu BL; Zhang X; Zhang YQ; Lin W; Wang R; Zhang YQ; Zhang HY; Xie L; Huo JL
    BMC Med Res Methodol; 2011 Apr; 11():56. PubMed ID: 21513533
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Translation and validation of the Chinese version of the Quality OF Life Radiation Therapy Instrument and the Head & Neck Module (QOL-RTI/H&N).
    Chen XL; Qiu ZW; Gu MF; Su Y; Liu LZ; Liu Y; Mo CW; Xu Q; Sun J; Li DH
    Health Qual Life Outcomes; 2014 Apr; 12():51. PubMed ID: 24731442
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Clinical and psychometric validation of a questionnaire module, the EORTC QLQ-STO 22, to assess quality of life in patients with gastric cancer.
    Blazeby JM; Conroy T; Bottomley A; Vickery C; Arraras J; Sezer O; Moore J; Koller M; Turhal NS; Stuart R; Van Cutsem E; D'haese S; Coens C;
    Eur J Cancer; 2004 Oct; 40(15):2260-8. PubMed ID: 15454251
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 33.